This federal contract, awarded by the Food and Drug Administration (FDA), a civilian agency, to International Business Machines Corporation (IBM), is for the provision of specialized programming and analytical support to the FDA's Center for Drug Evaluation and Research (CDER). The contract, which is a Blanket Purchase Agreement (BPA) call, has a ceiling value of $1,524,428.50 and a performance period that ends on September 15, 2025. The contract is not set aside for any specific business type. IBM, as a major federal IT and consulting services provider, frequently partners with small businesses, including minority-owned, woman-owned, and service-disabled veteran-owned firms, to deliver specialized services such as computer programming and IT consulting. This contract award is part of the Regulatory Review Support Services BPA, which allows various federal agencies to efficiently procure IBM's technology solutions and services, ranging from cloud migration and hosting to software development and data analytics, to support critical government operations.
Generated 12/20/24, 9:11 AM